Progress in drug development for Alzheimer’s disease (AD) has been slow. Drug repurposing — whereby new indications are identified for existing, well-studied drugs — has been explored for AD, but ...

CHICAGO--(BUSINESS WIRE)--Tempus, a leader in artificial intelligence and precision medicine, today announced a collaboration with JW Pharmaceutical, one of the most established pharmaceutical ...

First, institutions must ensure that synthetic datasets are continuously recalibrated against fresh, real-world evidence. The ...

Real-world data is invaluable to healthcare tech developers. This type of data reflects actual patient experiences, treatments and outcomes in diverse, real-world environments — rather than controlled ...

Navigating the world of data analytics can often feel like solving a complex puzzle. If you’ve already dipped your toes into Power BI and are eager to dive deeper, you’re in the right place. This ...